
Amazon Prime Free Trial
FREE Delivery is available to Prime members. To join, select "Try Amazon Prime and start saving today with FREE Delivery" below the Add to Cart button and confirm your Prime free trial.
Amazon Prime members enjoy:- Cardmembers earn 5% Back at Amazon.com with a Prime Credit Card.
- Unlimited FREE Prime delivery
- Streaming of thousands of movies and TV shows with limited ads on Prime Video.
- A Kindle book to borrow for free each month - with no due dates
- Listen to over 2 million songs and hundreds of playlists
Important: Your credit card will NOT be charged when you start your free trial or if you cancel during the trial period. If you're happy with Amazon Prime, do nothing. At the end of the free trial, your membership will automatically upgrade to a monthly membership.
Buy new:
-47% $14.96$14.96
Ships from: Amazon Sold by: SAYAKA MARKETING
Save with Used - Acceptable
$9.65$9.65
Ships from: Amazon Sold by: Goodwill Good Skills
Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required.
Read instantly on your browser with Kindle for Web.
Using your mobile phone camera - scan the code below and download the Kindle app.
Follow the author
OK
The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer Is Winnable--and How We Can Get There Hardcover – November 3, 2015
Purchase options and add-ons
Cancer touches everybody’s life in one way or another. But most of us know very little about how the disease works, why we treat it the way we do, and the personalities whose dedication got us where we are today. For fifty years, Dr. Vincent T. DeVita Jr. has been one of those key players: he has held just about every major position in the field, and he developed the first successful chemotherapy treatment for Hodgkin’s lymphoma, a breakthrough the American Society of Clinical Oncologists has called the top research advance in half a century of chemotherapy. As one of oncology’s leading figures, DeVita knows what cancer looks like from the lab bench and the bedside. The Death of Cancer is his illuminating and deeply personal look at the science and the history of one of the world’s most formidable diseases. In DeVita’s hands, even the most complex medical concepts are comprehensible.
Cowritten with DeVita’s daughter, the science writer Elizabeth DeVita-Raeburn, The Death of Cancer is also a personal tale about the false starts and major breakthroughs, the strong-willed oncologists who clashed with conservative administrators (and one another), and the courageous patients whose willingness to test cutting-edge research helped those oncologists find potential treatments. An emotionally compelling and informative read, The Death of Cancer is also a call to arms. DeVita believes that we’re well on our way to curing cancer but that there are things we need to change in order to get there. Mortality rates are declining, but America’s cancer patients are still being shortchanged―by timid doctors, by misguided national agendas, by compromised bureaucracies, and by a lack of access to information about the strengths and weaknesses of the nation’s cancer centers.
With historical depth and authenticity, DeVita reveals the true story of the fight against cancer. The Death of Cancer is an ambitious, vital book about a life-and-death subject that touches us all.
- Print length336 pages
- LanguageEnglish
- PublisherSarah Crichton Books
- Publication dateNovember 3, 2015
- Dimensions6.24 x 1.2 x 9.24 inches
- ISBN-109780374135607
- ISBN-13978-0374135607
Discover the latest buzz-worthy books, from mysteries and romance to humor and nonfiction. Explore more
Frequently bought together

Customers who viewed this item also viewed
Editorial Reviews
Review
“For the past half century, [DeVita] has been at the forefront of the fight against one of the world’s most feared diseases, and in The Death of Cancer he has written an extraordinary chronicle . . . his conclusions are deeply unsettling. . . DeVita’s portrait of the way things were gives us a glimpse at what the future may look like.” ―Malcolm Gladwell, The New Yorker
“A surprising and riveting story.” ―Chicago Tribune
“In The Death of Cancer, Dr. DeVita (with his daughter Elizabeth DeVita-Raeburn) paints a portrait of a cancer industrial complex desperately in need of an overhaul, hampered by petty politics and power mongering, among much else . . . Powerful . . . There is no mistaking the value of the core idea he wants to convey: that doctors and researchers commit themselves anew to doing everything possible to help the patient.” ―The Wall Street Journal
“An authoritative review of the history of surgery and radiation therapy . . . Ultimately, DeVita ably shows that the development of oncology as a modern specialty is a very human story.” ―The New York Times Book Review
“This riveting, beautifully written, and poignant memoir takes us on an enormous journey―from cancer’s past to its future. Vincent T. DeVita Jr. brings us behind the scenes to the invention of breakthrough therapies for some forms of cancer in the 1960s and ’70s. He also provides a much-needed manifesto for the future.” ―SIDDHARTHA MUKHERJEE, Pulitzer Prize–winning author of The Emperor of All Maladies
“An utterly absorbing memoir, fierce and frank . . . [T]he average reader will come away from the book with a superb basic education in all things oncological, from events on the cellular level to those in the rooms where research agendas are settled and checks are written.” ―The New York Times
“If ever a book about cancer could offer hope for the future, it’s this one.” ―New York Post
"[Dr. DeVita is] an eminent oncologist…[who]...became adept not only in cancer medicine but in cancer politics...DeVita rightly argues we are now at a much better place than we were in past decades.” ―The New York Review of Books
"In this engaging, provocative, and deeply personal book, Vincent DeVita and Elizabeth DeVita- Raeburn provide a compelling insider's guideinto the personalities, organizations, and key protagonists that provided the backdrop and impetus for the unprecedented campaign known as the war on cancer. . . The Death of Cancer presents a candid and disarming critique of the ways in which medicine, and specifically oncology, is regulated in the United States.” ―Science Magazine
“Great scientists are not always great writers, but this book is welcome exception, being well-crafted, compelling, transparent, and overall, optimistic.” ―Lancet Oncology
“A fascinating memoir … Siddhartha Mukherjee called his Pulitzer Prize winning “The Emperor of All Maladies’’ a “biography” of the disease. “The Death of Cancer’’ is its obituary. We’re at “the beginning of the end,” DeVita declares of the war on cancer.” ―The Boston Globe
“The Death of Cancer is an astonishingly good read. Written by a cancer expert who happens to be a cancer survivor as well, it deftly explains the treatments that have turned this insidious disease from a death sentence into a manageable chronic condition for millions of people―and what yet remains to be done. I devoured the book in two sittings, struck, page after page, by its insight, honesty, compassion, and plain common sense.” ―DAVID M. OSHINSKY, Pulitzer Prize–winning author of Polio: An American Story
“The Death of Cancer is a fascinating insider history of the long battle against one of the world’s most feared diseases, told with both insight and frustration, and ultimately with hope. This collaboration between the former National Cancer Institute director Vincent T. DeVita Jr. and his talented science writer daughter, Elizabeth DeVita-Raeburn, results in a wonderfully human portrait of the scientists who join the fight and a wonderfully smart look at the ways we might actually win it.” ―DEBORAH BLUM, New York Times–bestselling author of The Poisoner’s Handbook
“Superb science writing . . . One of the most absorbing and empowering science histories to hit the shelves in recent years.” ―Kirkus Reviews (starred review)
“DeVita blends crisp writing and a gift for explaining complicated scientific concepts clearly with deep knowledge, passion, and wit. The book is by turns entertaining and maddening, but always fascinating. Highly recommended” ―Library Journal (starred review)
"DeVita, an oncologist and professor at Yale School of Medicine, collaborates with his daughter DeVita-Raeburn on this engaging, informative, and inspiring history of DeVita’s prominent role in developing innovative cancer treatments . . . They also unveil some startling insights [and] offer salient advice . . . This remarkable memoir doesn’t just urge the public to have hope: it showcases the exciting evidence that we may finally be winning the war on cancer."
―Publishers Weekly (starred review)
"[A] straight-talking, optimistic memoir."
―Booklist
"An extraordinary book and an extraordinary story" ―Cancer Letter
About the Author
Vincent T. DeVita Jr., M.D. is a professor of medicine, epidemiology, and public health at the Yale School of Medicine. He was the director of the National Cancer Institute and the National Cancer Program from 1980 to 1988. In 1988 he joined Memorial Sloan Kettering Cancer Center as the physician in chief. In 1993 he became the director of the Yale Cancer Center. At the NCI, he developed a cure for Hodgkin’s lymphoma with combination chemotherapy, proving that advanced cancers can be cured by drugs. He is a former president of the American Cancer Society and the coeditor of Cancer: Principles & Practice of Oncology, a textbook of cancer medicine.
Elizabeth DeVita-Raeburn has written about medicine, science, and psychology for many publications. She is the author of The Empty Room: Understanding Sibling Loss. She lives in New York City with her husband, the writer Paul Raeburn, and their two sons.
Product details
- ASIN : 0374135606
- Publisher : Sarah Crichton Books; 1st edition (November 3, 2015)
- Language : English
- Hardcover : 336 pages
- ISBN-10 : 9780374135607
- ISBN-13 : 978-0374135607
- Item Weight : 1.25 pounds
- Dimensions : 6.24 x 1.2 x 9.24 inches
- Best Sellers Rank: #1,239,596 in Books (See Top 100 in Books)
- #789 in Oncology (Books)
- #1,865 in Cancer (Books)
- Customer Reviews:
About the author

Discover more of the author’s books, see similar authors, read book recommendations and more.
Customer reviews
Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.
To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.
Learn more how customers reviews work on AmazonCustomers say
Customers find the book well-written and informative. They appreciate the insightful biographies and in-depth review of cancer research. The history of cancer therapy and development of chemotherapy are engrossing. Readers praise the author's courage and tenacity in his quest to cure cancer.
AI-generated from the text of customer reviews
Customers find the book well-written and relatable. They appreciate the logical and clear explanations of complex information. The narrative is compelling and provides an overview of the U.S.'s fight against cancer.
"...The last chapters describe in a logical and clear manner the underlying pinning’s of the nature of cancer and the methods by which we can either “..." Read more
"...In a sense it is an Odyssey tale of a highly competent and prolific person who flows with his times and manages the Scylla and Charybdis of..." Read more
"...It's a really captivating story that extends past science to politics, lobbying and the public sentiment...." Read more
"...One of the most impressive books that I've ever read is Sid Mukherjee's Emperor of All Maladies, which tells the story of cancer in a very different..." Read more
Customers find the book informative and interesting. They appreciate the insightful biographies of two key figures. The book provides an in-depth review of how research has changed over the years. Readers appreciate the historical aspect and integration of scientific and clinical knowledge. Overall, it is described as a major resource and inspiring.
"...It is a demonstration of the integration of scientific and clinical knowledge across widely divergent areas of specialization and proposes a far..." Read more
"...on his involvement in the “War on Cancer” and the political games is quite interesting especially for anyone who has not spent a tour of duty in..." Read more
"...It's a really captivating story that extends past science to politics, lobbying and the public sentiment...." Read more
"...without a personal interest in the subject matter, but I found it enlightening and very helpful for understanding the why behind my husband's ordeal." Read more
Customers find the book informative and helpful for understanding cancer. They say it provides an interesting history of cancer therapy and the tremendous progress made. The book helps readers understand their condition and gives them hope for a better future. Readers appreciate the behind-the-scenes look at the politics and treatment options.
"...This is a paper on the hallmarks of cancer and is looked upon as a sine qua non in the literature. DeVita lauds it at length and rightly so...." Read more
"...students and physicians benefit from reading it, but people with a diagnosis of cancer (and their family members) will get inside perspective about..." Read more
"...Cure rates are high, but patients who relapse can be rescued with high-dose chemotherapy and autologous hematopoietic cell transplantation...." Read more
"...In summary, The Death of Cancer is a must read− if the reader understands that most of the book is about why we currently do NOT have the death of..." Read more
Customers appreciate the author's writing style. They find the book a well-written memoir about one person's quest to cure cancer. The format is autobiographical, which makes it more compelling. Readers appreciate the insightful explanation of the process and struggle of cancer research.
"...The book is co-written with his daughter, a professional science writer, who delivers his message in clear, straightforward prose...." Read more
"...The author of this marvelous book, Dr. DeVita, provided me with the information and inspiration to fight this disease...." Read more
"A well written memoir of one person's quest to cure cancer...." Read more
"...It was worth the wait. The joining of the lives and talents of both DeVita authors, bringing to print a life's history of monumental accomplishments,..." Read more
Customers praise the book for its courage and tenacity. They describe it as an inspiring portrait of a humane individual, and the brilliance and tenacity of many researchers and doctors.
"...definitive therapy for Hodgkin's disease, which has certainly stood the test of time...." Read more
"...saving the lives of others paints a portrait of a humane and courageous individual...." Read more
"...made in the fight against this disease, and the sacrifices made by brave individuals to leave a legacy that will benefit future generations...." Read more
"...I was encouraged by the brilliance and tenacity of so many researchers and doctors...." Read more
Reviews with images
The Non-Death of Cancer.
Top reviews from the United States
There was a problem filtering reviews right now. Please try again later.
- Reviewed in the United States on June 24, 2016It is indeed rare that I find a book or article so powerful that I believe that it should be widely read and discussed. Some works make valid points but are not of a nature that it impels us to rethink our previously held convictions or make us reexamine our basic understanding of a disease process. However, after reading and rereading parts of the Death of Cancer by Devita it is my conclusion that this work falls into that rare category of medical literature. I would therefore recommend that you read this book. Although this treatise is at times technical it should be well within the grasp of the lay reader.
If you are going to follow my recommendation to read this work than I also make the unusual suggestion that you read the last two chapters of the book first. This is not a mystery novel and you do not have to worry that you will ruin your enjoyment of the book because you already know “who did it”. I make this suggestion especially for the non-expert lay reader who will likely be bored by some of the details in the beginning of the book. The meat of this authoritative work is in the last two chapters, the penultimate chapter is entitled the “Death of Cancer” and the final chapter is “Outrageous Fortune Part 2”. Let me explain.
The first part of this book is about the history of the treatment of cancer since the 1960’s. To a great extent it is a polemic by the author castigating those involved in the treatment of cancer for their lack of progress, short sightedness, inability to think creatively, insular approach and unwillingness to innovate or accept the results of innovation. For the most part it is not a pretty picture and is in many ways disheartening. The author has an obvious bias and I am not completely certain that some of his observations and accusations should be taken at face value for it is possible that his observation reflect his own inability to understand the position of others. That is something that I am ill equipped to judge and I am sure that others with greater expertise will comment. Certainly feel free to read the book in its entirety but I want to be clear that my reason for recommending it lies in the last two chapters.
The last chapters describe in a logical and clear manner the underlying pinning’s of the nature of cancer and the methods by which we can either “cure” this dreaded disease or treat it as a chronic disease disorder such as diabetes. What Devita describes is not some pie in the sky vision of a possibility of future developments. It is technologically achievable today. Perhaps most important of all is that he has a realistic plan for rapidly implementing new discoveries in the treatment of cancer for the use of the public at large.
Some of the language in the final chapters is technically difficult but do not worry about that. If you do not understand a word or phrase it is likely that he will make it clear as you read further. The important point to understand is that we have now arrived at the point where we have the tools in our hands to radically change what we have been doing. This is indeed a paradigm shift. It requires a new way of thinking about a common problem and promises results that are far better than we could have expected as little as five years ago. It is a demonstration of the integration of scientific and clinical knowledge across widely divergent areas of specialization and proposes a far more advanced model of care.
Some will reject the conclusions of this book because they may be either antithetical to their belief system or they view it as philosophically disingenuous. To those I would comment that if your opinion is based on hard evidence then I respect it and would appreciate further debate. However, I personally have little tolerance for those who reject these propositions based on an irrational conservatism that in essence says we do it this way because that is what we have always done it. That method of thought should be an anathema to the scientific integrity of our profession and is harmful to the public at large. For those who argue “first do no harm” it is clear that for those who desire reasonable treatment then patient autonomy trumps our individual pessimism. I am not arguing for futile care for that does violate other important medical principles. I firmly believe as a family physician that all physicians interacting with those who have serious illness have a responsibility to fully educate their patients and themselves about what is available and the consequences of making an either positive or negative decision about treatment. This book supplies some of the basic knowledge necessary to participate in that essential medical decision making process.
- Reviewed in the United States on December 4, 2015DeVita’s book, The Death of Cancer, is a personal recollection of one of the most well-known cancer specialists in the world. In a sense it is an Odyssey tale of a highly competent and prolific person who flows with his times and manages the Scylla and Charybdis of Government work. The book is well written and reflective of the man and his times. DeVita started out during the Vietnam era when any male graduating from Med School found themselves, unless otherwise excused, ready for immediate assignment to some military unit. Many of the top students were fortunate to get to go to NIH which was DeVita’s fate, and it was this flow of talent in the late 60s which made NIH and NCI one of the best institutions in the world. Thus the tale of DeVita and cancer starts here with NCI and a flow of excellent talent.
DeVita describes his work on the use of multiple chemotherapy regimens and the resistance from the likes of Farber in Boston, hardly an uncommon occurrence especially in Medicine. This was the MOPP therapy that most now know as a major breakthrough in Hodgkin’s. The discussion on how he and the team managed to persist and managed to go through the then significant administrative a bureaucratic complexities is amazing.
The discussion on his involvement in the “War on Cancer” and the political games is quite interesting especially for anyone who has not spent a tour of duty in Washington. There were games within games and DeVita was at times a willing participant but as see in the book and excellent observer. His description of the political gamesmanship is worth the read if nothing else. It is also worth the while for anyone seeking to grasp how Washington functions, and why it may work at times and often falls into total disarray.
On p. 159 I was interested to see the interlocutory between Benno Schmidt and Jim Watson while Watson was I gather performing one of his classic poses. This also is worth the read. I have had my students return from a talk by Watson and ask me: “Does he really think Physicians and Engineers are useless?” But I gather that is Watson, a scientist at heart.
On p 219 there is a great discussion of his time at MSKCC, a world renowned institution but at times falling behind in certain areas. DeVita states: “MSKCC had the potential to be the best cancer center in the world, it wasn’t” is a powerful statement and at times quite true. MSKCC has powerful backers and Board members and although it may try from time to time to be at the lead there is always the chance that it becomes insular. The lesson DeVita brings out here should be a warning for many such institutions.
On p 247 DeVita discusses the recent Hanahan and Weinberg paper on Cancer, a follow on to what the two authors had written in 2000. This is a paper on the hallmarks of cancer and is looked upon as a sine qua non in the literature. DeVita lauds it at length and rightly so. Yet what this paper also shows is that we have learned a great deal but the “War on Cancer” is just getting harder the more we learn. One could argue that the recent Hanahan and Weinberg paper albeit prescient and insightful lacks the depth on epigenetic factors which we are seeing more and more in cancers. The more that is learned the more complex the disease.
On p 253 DeVita discusses the inflammation relationship. We often ask what causes cancer and the more we understand inflammation the more we can see the nexus. This is a useful and important discussion as well.
On p 258 DeVita makes an interesting statement:
“In my opinion, when there is less than a 10% chance of the cancer recurring after a patient passes his or her cancer’s critical period, then the patient should be told, in all likelihood, he or she is cured.”
This is a powerful statement and one a physician with extensive clinical experience is wont to utter. However one should parse the statement. First, how does one determine a 10% chance? In prostate cancer we can perform a prostatectomy and monitor PPSA for several years and then see a met occur. When did the 10% level occur? Second, what is a critical period? How do we define it for each cancer? Then the catch phrase of “in all likelihood” is something the patient may or most likely not hear. Cancer patients often has selective hearing.
Overall the book is highly enlightening and a must read for anyone interested in the progression of cancer therapy. Also DeVita’s discussion of his battles with the FDA and Sen. Kennedy’s blatant interference with NCI if it in his opinion interfered with the FDA was quite interesting. DeVita bares the political quagmires of Washington and demonstrates that progress can often be made despite the Government overhead by dedicated and highly competent individuals.
- Reviewed in the United States on June 3, 2016The history of NCI and the War on Cancer is thoroughly discussed in this book, from its inception to the present day. It's a really captivating story that extends past science to politics, lobbying and the public sentiment. The confluence of all of this makes it engaging and grandiose. There are few if any people in the world that have played as consistently an important role in where cancer research stands today as the author has.
While the story is fantastic, this book dealt almost entirely with the past until the last chapter or two (if I recall correctly, the second last chapter is on in which you finally get a very technical summary of everything that has been learned about science in the past 50+ years. And then there's a brief account of recent advancements in immunotherapy. While these are not the focus of this book, and rightfully so, more pages dedicated to these topics could have been a nice addition).
The writer rightfully discusses many of the shortcomings of the FDA, and highlights the problems with their approach to cancer in great detail, however he appears to sort of gloss over the solutions. This topic could surely be a book in itself, however I think even just a few more sentences dedicated to elaborating on how clinical trials could be carried out more effectively would make the arguments he set up for much more emphatic.
Overall, highly recommended this book.
Top reviews from other countries
Peter R.Reviewed in Canada on August 4, 20175.0 out of 5 stars The good thing is that the field seems to be moving ...
This book is an opportunity to look inside the world of cancer treatment in clinic (which as it turns out is less than ideal). As the author tells us, human factor plays a major role in the fate of cancer patients and the outcome is highly affected by different conflicts of interest the doctors may have. The good thing is that the field seems to be moving forward and one of the things everyone can do to improve the chances for themselves or their loved ones is to get educated on the subject and all the existing options. This book is a very good source of such education.
Jean Charles soriaReviewed in France on August 21, 20165.0 out of 5 stars Great personal perspective on cancer care
Vince De Vita is a giant in oncology
His personal perspective on how to treat cancer and the key-steps to overcome this disease are inspirational and of real interest
-
Fernando Gomollon GarciaReviewed in Spain on February 10, 20165.0 out of 5 stars Un visión personal de un verdadero pionero en el diagnóstico y tratamiento del cáncer
No espere buena literatura en este libro, no espere tampoco disimulo. Espere una visión desgarrada, personal, experta, esperanzada y decepcionada a la vez de lo que es luchar contra el cáncer de verdad, en el frente de batalla de la consulta y en el despacho del Estado Mayor, en la sección de planificación, y en la investigación y desarrollo. Y espere, también, una crítica a la burocratización del sistema, a la lentitud de las agencias reguladoras, tan necesarias y tan superfluas, a la vez. Eso sí, una vez que empiece no podrá parar de leer.
StefanoReviewed in the United Kingdom on February 8, 20165.0 out of 5 stars This book should be on every oncologist's and member of parliament's desk!!
Amazing book and author. I just lost my young wife to cancer. This book should be on every oncologist's and member of parliament's desk. Based on my personal painful experience, I agree with each and every comment and recommendation that DeVita makes. We are finally starting to have 21st century tools against cancer, but we are still stuck with mid-20th century medical regulations and attitudes, even more so in the UK than in the USA. This is the time to take risks in return for greater benefits; the cancer community should learn from what the AIDS community did in the mid 90's.
Read it and give it to any decision makers in cancer treatment!
S. SankarReviewed in India on January 13, 20165.0 out of 5 stars I would recommend this book to be read by anyone interested in ...
Story on the evolution of medical oncology and the war on cancer. Insiders view on how the US national policies on the campaign against cancer were shaped by activism and lobbying with the Government by indomitable and courageous individuals. I would recommend this book to be read by anyone interested in the fight against cancer and to get an idea of how public policy on health and diseases can be built with vision and passion.






